Glaucius Oliva São Carlos Institute of Physics University of Sao Paulo Biography Publications Institution JoVE Articles Glaucius Oliva has not added a biography. If you are Glaucius Oliva and would like to personalize this page please email our Author Liaison for assistance. Publications Non-Toxic Dimeric Peptides Derived from the Bothropstoxin-I Are Potent SARS-CoV-2 and Papain-like Protease Inhibitors Molecules (Basel, Switzerland). Aug, 2021 | Pubmed ID: 34443484 Machine Learning Models Identify Inhibitors of SARS-CoV-2 Journal of Chemical Information and Modeling. 09, 2021 | Pubmed ID: 34387990 Development of Machine Learning Models and the Discovery of a New Antiviral Compound Against Yellow Fever Virus Journal of Chemical Information and Modeling. 08, 2021 | Pubmed ID: 34286575 A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process Journal of Molecular Biology. 09, 2021 | Pubmed ID: 34174328 Discovery of an Imidazonaphthyridine and a Riminophenazine As Potent Anti-Zika Virus Agents Through a Replicon-based High-throughput Screening Virus Research. Jul, 2021 | Pubmed ID: 33887282 Flavonoids from Pterogyne Nitens As Zika Virus NS2B-NS3 Protease Inhibitors Bioorganic Chemistry. 04, 2021 | Pubmed ID: 33636437 Reporter Replicons for Antiviral Drug Discovery Against Positive Single-Stranded RNA Viruses Viruses. 05, 2020 | Pubmed ID: 32486283 Structural Characterization and Polymorphism Analysis of the NS2B-NS3 Protease from the 2017 Brazilian Circulating Strain of Yellow Fever Virus Biochimica Et Biophysica Acta. General Subjects. 04, 2020 | Pubmed ID: 31931019 Discovery of Potent, Reversible, and Competitive Cruzain Inhibitors with Trypanocidal Activity: A Structure-Based Drug Design Approach Journal of Chemical Information and Modeling. 02, 2020 | Pubmed ID: 31765144 Antiplasmodial Profile of Selected Compounds from Malaria Box: in Vitro Evaluation, Speed of Action and Drug Combination Studies Malaria Journal. Dec, 2019 | Pubmed ID: 31888654 A Diarylamine Derived from Anthranilic Acid Inhibits ZIKV Replication Scientific Reports. 11, 2019 | Pubmed ID: 31776405 Structural and Mechanistic Insight from Antiviral and Antiparasitic Enzyme Drug Targets for Tropical Infectious Diseases Current Opinion in Structural Biology. 12, 2019 | Pubmed ID: 30954758 New Molecular Targets and Strategies for Antimalarial Discovery Current Medicinal Chemistry. 2019 | Pubmed ID: 28875841 Phthalimide Derivatives with Bioactivity Against : Synthesis, Evaluation, and Computational Studies Involving Cytochrome Inhibition ACS Omega. Aug, 2018 | Pubmed ID: 31459076 Discovery of Marinoquinolines As Potent and Fast-Acting Plasmodium Falciparum Inhibitors with in Vivo Activity Journal of Medicinal Chemistry. 07, 2018 | Pubmed ID: 29879353 Crystal Structure of Zika Virus NS5 RNA-dependent RNA Polymerase Nature Communications. 03, 2017 | Pubmed ID: 28345596 Molecular Docking and Structure-based Drug Design Strategies Molecules (Basel, Switzerland). Jul, 2015 | Pubmed ID: 26205061 In Silico Screening Strategies for Novel Inhibitors of Parasitic Diseases Expert Opinion on Drug Discovery. May, 2011 | Pubmed ID: 22646074 Cloning, Characterization and Preliminary Crystallographic Analysis of Leishmania Hypoxanthine-guanine Phosphoribosyltransferase Biochimica Et Biophysica Acta. Jul, 2002 | Pubmed ID: 12147338 High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication Rafaela S. Fernandes1, Gabriela D. Noske1, Victor O. Gawriljuk1, Ketllyn I. Z. de Oliveira1, Andre S. Godoy1, Nathalya C. M. R. Mesquita1, Glaucius Oliva1 1São Carlos Institute of Physics, University of Sao Paulo JoVE 62422 Immunology and Infection
High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication Rafaela S. Fernandes1, Gabriela D. Noske1, Victor O. Gawriljuk1, Ketllyn I. Z. de Oliveira1, Andre S. Godoy1, Nathalya C. M. R. Mesquita1, Glaucius Oliva1 1São Carlos Institute of Physics, University of Sao Paulo JoVE 62422 Immunology and Infection
